KR102239074B9 - IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Obesity Comprising IF1 - Google Patents

IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Obesity Comprising IF1

Info

Publication number
KR102239074B9
KR102239074B9 KR1020190110741A KR20190110741A KR102239074B9 KR 102239074 B9 KR102239074 B9 KR 102239074B9 KR 1020190110741 A KR1020190110741 A KR 1020190110741A KR 20190110741 A KR20190110741 A KR 20190110741A KR 102239074 B9 KR102239074 B9 KR 102239074B9
Authority
KR
South Korea
Prior art keywords
preventing
composition
inhibitory factor
treating obesity
atpase inhibitory
Prior art date
Application number
KR1020190110741A
Other languages
Korean (ko)
Other versions
KR20200031998A (en
KR102239074B1 (en
Inventor
신민정
김현수
정지형
Original Assignee
고려대학교 산학협력단
차의과학대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고려대학교 산학협력단, 차의과학대학교 산학협력단 filed Critical 고려대학교 산학협력단
Publication of KR20200031998A publication Critical patent/KR20200031998A/en
Application granted granted Critical
Publication of KR102239074B1 publication Critical patent/KR102239074B1/en
Publication of KR102239074B9 publication Critical patent/KR102239074B9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1761—Apoptosis related proteins, e.g. Apoptotic protease-activating factor-1 (APAF-1), Bax, Bax-inhibitory protein(s)(BI; bax-I), Myeloid cell leukemia associated protein (MCL-1), Inhibitor of apoptosis [IAP] or Bcl-2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020190110741A 2018-09-14 2019-09-06 Composition for Preventing or Treating Obesity Comprising IF1 KR102239074B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180110413 2018-09-14
KR20180110413 2018-09-14

Publications (3)

Publication Number Publication Date
KR20200031998A KR20200031998A (en) 2020-03-25
KR102239074B1 KR102239074B1 (en) 2021-04-14
KR102239074B9 true KR102239074B9 (en) 2022-03-15

Family

ID=70001890

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190110741A KR102239074B1 (en) 2018-09-14 2019-09-06 Composition for Preventing or Treating Obesity Comprising IF1

Country Status (1)

Country Link
KR (1) KR102239074B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4268839A1 (en) * 2020-12-22 2023-11-01 Medi & Gene Pharmaceutical composition for preventing or treating alcoholic and nonalcoholic fatty liver disease
CN117858716A (en) * 2021-06-28 2024-04-09 高丽大学校产学协力团 Peptides having obesity and muscle loss inhibiting activity and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034833A2 (en) 1999-11-10 2001-05-17 Mitokor Regulating endogenous inhibitor at atp synthase
US20150065556A1 (en) 2013-08-05 2015-03-05 Whitehead Institute For Biomedical Research Therapeutic targets for mitochondrial disorders

Also Published As

Publication number Publication date
KR20200031998A (en) 2020-03-25
KR102239074B1 (en) 2021-04-14

Similar Documents

Publication Publication Date Title
KR102223657B9 (en) COMPOSITION FOR PREVENTING OR TREATING Inflammatory Bowel Disease
KR102239075B9 (en) IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Sarcopenia Comprising IF1
EP3818085A4 (en) Compositions and uses thereof for treating disease or condition
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
IL285886A (en) Compositions and methods for treating laminopathies
ZA201907974B (en) Agent for preventing or treating spinocerebellar ataxia
KR102239074B9 (en) IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Obesity Comprising IF1
EP3773539A4 (en) Compositions for treating skin
IL261774B (en) Compositions for treating dermatological conditions
GB202001422D0 (en) Compositions and methods for preventing or treating nephrolithiasis
KR102248110B9 (en) IF1 ATPase inhibitory factor 1 Anti-Cancer Composition Comprising IF1
PT3810128T (en) Compositions for treating and/or preventing protein-aggregation diseases
KR102276379B9 (en) IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Bone Diseases Comprising IF1
IL285796A (en) Methods and compositions for treating
IL282692A (en) Madrasin-derivative compounds, composition and uses thereof for treating cancer
ZA202007616B (en) Pharmaceutical composition for preventing or treating aids comprising rhodanine derivative
ZA202006591B (en) Compositions for the treatment of hypertension
FI3758799T3 (en) Composition for the prevention and treatment of skin damages caused by photo-exposure
EP3811973A4 (en) Composition for preventing or treating neurodegenerative disease
EP3750550A4 (en) Composition for preventing or treating osteoporosis
KR102316727B9 (en) Pharmaceutical composition for preventing or treating atopic diseases
EP3760199A4 (en) Composition for preventing or treating hair loss
IL282557A (en) Composition for preventing or treating sjogren's syndrome
ZA202100281B (en) Water-in-oil coating composition
ZA202100065B (en) Water-in-oil coating composition

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]